"What" Series

What is post marketing research?

21 December 2023
2 min read

According to pharmacoepidemiology: post marketing research of drugs refers to the research on the use and effect of drugs following a specific research scheme after they are approved for marketing. Post marketing research of drugs includes clinical trials, investigations (such as observational epidemiological studies, post marketing clinical safety re evaluation, etc.) and laboratory studies, which are usually divided into two parts: post marketing requirements (PMR) and post marketing commitments (PMC). 

(1) Evaluate the benefits and risks of drug use in general or special populations 

(2) evaluate the effectiveness of drugs under conditions of widespread use 

(3) evaluate the known serious risks related to drug use 

(4) evaluate the serious risk signals related to drug use 

(5) find potential unexpected serious risks 

(6) Improve the pre marketing effectiveness data of drugs 

(7) improve the clinical pharmacology information (food and drug administration.

GigaGen Receives Authorization from FDA to Initiate Phase 1 Study of Cancer Drug GIGA-564 for Solid Tumor Treatment
Latest Hotspot
3 min read
GigaGen Receives Authorization from FDA to Initiate Phase 1 Study of Cancer Drug GIGA-564 for Solid Tumor Treatment
20 December 2023
GigaGen Inc. has announced FDA approval for its IND application. This permits the start of a Phase 1 trial to evaluate GIGA-564's effectiveness in treating diverse solid cancers.
Read →
Understanding Protein kinases Inhibitors and Methods to Keep Abreast of Their Recent Developments
Understanding Protein kinases Inhibitors and Methods to Keep Abreast of Their Recent Developments
20 December 2023
Protein kinase inhibitors are drugs that target protein kinases, crucial in cell signaling and regulation. The future sees potential applications in treating various diseases, particularly cancer.
Read →
UNITY Biotechnology Begins Phase 2 ASPIRE Trial Administering UBX1325 to Initial Participants with Diabetic Macular Edema
Latest Hotspot
3 min read
UNITY Biotechnology Begins Phase 2 ASPIRE Trial Administering UBX1325 to Initial Participants with Diabetic Macular Edema
20 December 2023
Biotech company UNITY Biotechnology has launched its Phase 2 ASPIRE trial, administering its aging-focused drug UBX1325 (foselutoclax) to the first patients.
Read →
How to identify antibody sequences?
Knowledge Base
2 min read
How to identify antibody sequences?
20 December 2023
Antibody sequences can be identified via PCR, NGS, and bioinformatics analysis tools.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.